Cantor Fitzgerald, L. P. »

An2 Therapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2026-03-31 $684k 200k 3.42

More positions owned by Cantor Fitzgerald, L. P.

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Advanced Micro Devices Put Option (AMD)
Strategy Cl A New (MSTR)
Tesla Motors (TSLA)
Iren Ordinary Shares (IREN)
UnitedHealth Put Option (UNH)
Circle Internet Group Com Cl A Put Option (CRCL)
Broadcom (AVGO)
Bitmine Immersion Tecnologie Com New (BMNR)
Robinhood Mkts Com Cl A (HOOD)
Intel Corporation (INTC)
Servicenow Put Option (NOW)
Oracle Corporation (ORCL)
Amazon (AMZN)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding An2 Therapeutics

Vivo Capital
Commodore Capital
Millennium Management
Almitas Capital
Vanguard Group
Vanguard Capital Management
Woodline Partners
Ameriprise Financial
Stonepine Capital Management
Ally Bridge Group
Bank of Nova Scotia
Bank of America Corporation
Renaissance Technologies
BlackRock
Jane Street

View all funds holding An2 Therapeutics